News
TPG, Lyft, and GeneDX announced deals; Onsemi, meanwhile, ended discussions after offering its target $35.10 per share.
The company's bankruptcy has spotlighted the vulnerability of private consumer genetic testing data.
Three congressmen on the House Committee on Energy and Commerce sent a letter to the genetic testing company 23andMe on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results